Drug Topics
FEBRUARY 15, 2025
Currently, blood-thinning medications are only prescribed to patients who have already had a heart attack or stroke, as the drugs can cause serious bleeding.
Pharmacy Times
FEBRUARY 15, 2025
Data from the phase 2 CABRAMET trial suggests the potential of cabozantinib for treatment of brain metastases from renal cell carcinoma (RCC).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmExec
FEBRUARY 15, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
FEBRUARY 15, 2025
C. Brooke Adams, PharmD, BCOP, discusses the evolving diagnostic criteria and management strategies for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR T-cell therapy, highlighting advances in toxicity prevention and treatment selection.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
FEBRUARY 15, 2025
Every couple of weeks I travel to Princeton University to do archival research for a planned biography of the physician-humanist Lewis Thomas (1913-1993). Thomas was president of Memorial Sloan-Kettering Cancer Center, author of “ The Lives of a Cell ,” and winner of two National Book Awards and a 1989 Lasker Prize , which heralded him as “the poet laureate of 20th Century medicine.
Pharmacy Times
FEBRUARY 15, 2025
Enfortumab vedotin, trastuzumab deruxtecan, and disitamab vedotin were highlighted at the 2025 ASCO Genitourinary Cancers Symposium.
Pharmacy Times
FEBRUARY 15, 2025
A one-time infusion of etranacogene dezaparvovec-drlb led to sustained bleeding control and a reduction in factor IX prophylaxis in patients with hemophilia B.
Expert insights. Personalized for you.
247 
Let's personalize your content